drugset / Trial / NCT05023031
Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics and safety of NVP-2102 and NVP-2102-R.
Timeline
- Start
- 2021-10-05
- Primary completion
- 2021-12-24
- Completion
- 2022-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVP-2102 | Unknown | — | Oral |
| Comparator | NVP-2102-R | Unknown | — | Oral |
Indications
No indication recorded.